Crinetics Pharmaceuticals
Utility Patents
Last updated:
List of all Crinetics Pharmaceuticals patents 13 in total
| Status | Patent |
|---|---|
Grant | Utility: Formulations of a somatostatin modulator Filling date: 8 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Somatostatin modulators and uses thereof Filling date: 8 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: Somatostatin modulators and uses thereof Filling date: 8 Sep 2025 Issue date: 27 Jul 2021 |
Grant | Utility: Somatostatin modulators and uses thereof Filling date: 8 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Filling date: 8 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Process of making somatostatin modulators Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 |
Grant | Utility: Somatostatin modulators and uses thereof Filling date: 8 Sep 2025 Issue date: 29 Dec 2020 |
Grant | Utility: Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Filling date: 8 Sep 2025 Issue date: 8 Sep 2020 |
Grant | Utility: Somatostatin modulators and uses thereof Filling date: 8 Sep 2025 Issue date: 30 Jun 2020 |
Grant | Utility: Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Filling date: 8 Sep 2025 Issue date: 31 Mar 2020 |
Grant | Utility: Somatostatin modulators and uses thereof Filling date: 8 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Filling date: 8 Sep 2025 Issue date: 18 Feb 2020 |
Grant | Utility: Process of making somatostatin modulators Filling date: 8 Sep 2025 Issue date: 5 Nov 2019 |
Showing 1 to 13 of 13 patents.